EXEL vs TFX: fair value comparison
Exelixis, Inc. and Teleflex Incorporated · Updated 2026-09-13
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, EXEL currently sits closer to the top of our discount ranking. EXEL carries the stronger quality grade.
| EXEL | TFX | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $56.89 | $140.48 |
| 12-month range | $38.06–$56.89 | $103.36–$140.48 |
| Sector rank | #53 of 113 Healthcare | #57 of 113 Healthcare |
| Quality grade | A | C |
| Leverage | Low | Moderate |
| Margin trend | Stable | Contracting |
| Revenue growth | Strong | Declining |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | — |
| DCF cross-check | Undervalued | Overvalued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: EXEL fair value analysis · TFX fair value analysis